Targeted Delivery of VEGF-siRNA to Glioblastoma Using Orientation-Controlled Anti-PD-L1 Antibody-Modified Lipid Nanoparticles

Ayaka Matsuo-Tani, Shigeru Kawakami, Takeshi Hiu et al.|Pharmaceutics|2025

Cited by 5